Skip to content

Basil in insomnia

Evaluation of possible hypnotic impact of basil (Ocimum basilicum) made product on patient suffering from insomnia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180103038199N1
Enrollment
100
Registered
2018-05-04
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia. Primary insomnia

Interventions

Intervention 1: Control group: receiving the same form of capsule prepared from basil extract with starch powder without basil in form of 500 mg unique shapes for all groups. It is noteworthy that the

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: primary sleep disorders Willing to cooperate Defined conditions of initial insomnia according to DSM-V for at least three months Lack of illnesses such as pulmonary diseases, allergic rhinitis, heart disease, infectious diseases, cancers Lake of Mental Illness: Like Depression No neurological disease like Parkinson's, Alzheimer's Lack of sleep disorders such as sleep apnea

Exclusion criteria

Exclusion criteria: Pregnant and lactating women History of allergy to medicinal herbs Unwillingness to continue cooperation for any reason

Design outcomes

Primary

MeasureTime frame
Changing the score in the Pittsburgh Questionnaire. Timepoint: Before the beginning of the study and at the end of the study. Method of measurement: Based on the Pittsburgh Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hassan Rakhshandeh

Mashhad University of Medical Sciences

Rakhshandehh@mums.ac.ir+98 915 503 6929

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026